Palisade Bio Inc.

NASDAQ: PALI · Real-Time Price · USD
0.82
0.01 (0.61%)
At close: Aug 15, 2025, 2:54 PM

Palisade Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-14.44M -12.3M -14.26M -26.62M
Depreciation & Amortization
3K 4K 3K 2K
Stock-Based Compensation
652K 624K 1.03M 1.89M
Other Working Capital
573K 892K 851K -2.36M
Other Non-Cash Items
199K 139K -1.39M 34.77M
Deferred Income Tax
n/a n/a n/a -20.07M
Change in Working Capital
1.39M 400K 1.25M -4.76M
Operating Cash Flow
-12.19M -11.13M -13.36M -14.77M
Capital Expenditures
n/a -4K -10K n/a
Cash Acquisitions
n/a n/a n/a -54K
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -54K
Investing Cash Flow
n/a -4K -10K -54K
Debt Repayment
-426K -391K -790K -183K
Common Stock Repurchased
11K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.57M 2.16M 1.65M -317K
Financial Cash Flow
9.58M 11.19M 15.26M 24.61M
Net Cash Flow
-2.61M 49K 1.89M 9.78M
Free Cash Flow
-12.19M -11.14M -13.37M -14.77M